Martin Basedow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Martin Basedow has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Esterman
University of South Australia, Adelaide, Australia
4 shared publications - William Ben Runciman
Australian Centre for Precision Health, University of South Australia,Adelaide,Australia
3 shared publications - Ernst Michael Shanahan
Flinders University
1 shared publication - Helena Williams
Division of Paediatric Medicine, Women's and Children's Health Network, SA Health, Adelaide, Australia
1 shared publication - Lyn March
Sutton Arthritis Research Laboratory, The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia
1 shared publication - Wendy Lipworth
Department of Philosophy, Macquarie University, Sydney, NSW, Australia
1 shared publication
Latest Publications
- Open Access
- 5 October 2015
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 1-8
Australian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis
Osteoarthritis (OA) is a highly disabling and costly condition with an escalating prevalence in Australia due to the ageing and increasing obesity of the population. The general practitioner (GP) plays a central role in the management of this condition. The aim of this study was to examine opinions about the management of OA by Australian GPs following the release of the Royal Australian College of General Practitioners Guideline for the non-surgical management of hip and knee OA (RACGP OA CPG), and to compare the results with an earlier survey administered by the National Prescribing Service. In January 2013, a self-administered questionnaire was sent to 228 GPs to determine their treatment approaches to OA management using a clinical vignette of a patient with OA. This was compared with results from a similar survey undertaken in 2006. Seventy-nine GPs returned questionnaires (response rate 35 %). GP recommendations for paracetamol, a paracetamol/codeine compound, and oral non-steroidal anti-inflammatory drugs (NSAIDs) were consistent with recommendations in the RACGP OA CPG, and varied little from the previous survey. Notably, there was a marked increase between surveys in GP recommendations for tramadol (p = 0.004) and more potent opioids (p < 0.001). Advice about the adverse effects of NSAIDs and codeine and how to manage them increased between surveys (p = 0.038 and 0.005, respectively). For all non-pharmacological treatments, there were only minor changes in the percentage of GP recommendations when compared with the previous survey, however they remain underutilised. GPs generally demonstrated a conservative approach to the treatment of OA, however, the increased recommendations for more potent opioids warrants further investigation. Patients should be made aware of the risks of medications through the use of decision aids, which can provide structured guidance to treatment. Non-pharmacological interventions were not given the importance that is suggested by clinical practice guidelines.
- 5 October 2015
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 1-8
Open AccessAustralian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis
Osteoarthritis (OA) is a highly disabling and costly condition with an escalating prevalence in Australia due to the ageing and increasing obesity of the population. The general practitioner (GP) plays a central role in the management of this condition. The aim of this study was to examine opinions about the management of OA by Australian GPs following the release of the Royal Australian College of General Practitioners Guideline for the non-surgical management of hip and knee OA (RACGP OA CPG), and to compare the results with an earlier survey administered by the National Prescribing Service. In January 2013, a self-administered questionnaire was sent to 228 GPs to determine their treatment approaches to OA management using a clinical vignette of a patient with OA. This was compared with results from a similar survey undertaken in 2006. Seventy-nine GPs returned questionnaires (response rate 35 %). GP recommendations for paracetamol, a paracetamol/codeine compound, and oral non-steroidal anti-inflammatory drugs (NSAIDs) were consistent with recommendations in the RACGP OA CPG, and varied little from the previous survey. Notably, there was a marked increase between surveys in GP recommendations for tramadol (p = 0.004) and more potent opioids (p < 0.001). Advice about the adverse effects of NSAIDs and codeine and how to manage them increased between surveys (p = 0.038 and 0.005, respectively). For all non-pharmacological treatments, there were only minor changes in the percentage of GP recommendations when compared with the previous survey, however they remain underutilised. GPs generally demonstrated a conservative approach to the treatment of OA, however, the increased recommendations for more potent opioids warrants further investigation. Patients should be made aware of the risks of medications through the use of decision aids, which can provide structured guidance to treatment. Non-pharmacological interventions were not given the importance that is suggested by clinical practice guidelines.
- 5 October 2015
- Published by CSIRO Publishing in Australian Journal of Primary Health
- Vol. 22 (5) , 403-408
Australian general practitioner attitudes to clinical practice guidelines and some implications for translating osteoarthritis care into practice
Clinical practice guidelines (CPGs) have been shown to improve processes of care and health outcomes, but there is often a discrepancy between recommendations for care and clinical practice. This study sought to explore general practitioner (GP) attitudes towards CPGs, in general and specifically for osteoarthritis (OA), with the implications for translating OA care into practice. A self-administered questionnaire was conducted in January 2013 with a sample of 228 GPs in New South Wales and South Australia. Seventy-nine GPs returned questionnaires (response rate 35%). Nearly all GPs considered that CPGs support decision-making in practice (94%) and medical education (92%). Very few respondents regarded CPGs as a threat to clinical autonomy, and most recognised that individual patient circumstances must be taken into account. Shorter CPG formats were preferred over longer and more comprehensive formats, with preferences being evenly divided among respondents for short, 2–3-page summaries, flowcharts or algorithms and single page checklists. GPs considered accessibility to CPGs to be important, and electronic formats were popular. Familiarity and use of The Royal Australian College of General Practitioners OA Guideline was poor, with most respondents either not aware of it (30%; 95% confidence interval (CI) 27 – 41%), had never used it (19%; 95% CI 12 – 29%) or rarely used it (34%; 95% CI 25–45%). If CPGs are to assist with the translation of evidence into practice, they must be easily accessible and in a format that encourages use.
- 5 October 2015
- Published by CSIRO Publishing in Australian Journal of Primary Health
- Vol. 22 (5) , 403-408
Australian general practitioner attitudes to clinical practice guidelines and some implications for translating osteoarthritis care into practice
Clinical practice guidelines (CPGs) have been shown to improve processes of care and health outcomes, but there is often a discrepancy between recommendations for care and clinical practice. This study sought to explore general practitioner (GP) attitudes towards CPGs, in general and specifically for osteoarthritis (OA), with the implications for translating OA care into practice. A self-administered questionnaire was conducted in January 2013 with a sample of 228 GPs in New South Wales and South Australia. Seventy-nine GPs returned questionnaires (response rate 35%). Nearly all GPs considered that CPGs support decision-making in practice (94%) and medical education (92%). Very few respondents regarded CPGs as a threat to clinical autonomy, and most recognised that individual patient circumstances must be taken into account. Shorter CPG formats were preferred over longer and more comprehensive formats, with preferences being evenly divided among respondents for short, 2–3-page summaries, flowcharts or algorithms and single page checklists. GPs considered accessibility to CPGs to be important, and electronic formats were popular. Familiarity and use of The Royal Australian College of General Practitioners OA Guideline was poor, with most respondents either not aware of it (30%; 95% confidence interval (CI) 27 – 41%), had never used it (19%; 95% CI 12 – 29%) or rarely used it (34%; 95% CI 25–45%). If CPGs are to assist with the translation of evidence into practice, they must be easily accessible and in a format that encourages use.
- 17 June 2015
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 21 (5) , 782-789
Assessing appropriateness of osteoarthritis care using quality indicators: a systematic review
Rationale, aims and objectives: Quality indicators (QIs) derived from the review of medical records, administrative databases, and patient questionnaires and interviews have been frequently used to assess the quality of osteoarthritis (OA) care. The purpose of this review is to summarize studies that have assessed the quality of OA care using QIs.Method: We systematically searched MEDLINE, EMBASE, CINAHL and PsycINFO for English‐language studies indexed by October 2014. Articles were included if they used any QIs for assessing the quality of OA care. We summarized the results of these studies, and with meta‐analysis, generated an overall conclusion about the quality of care as measured by QIs for each treatment domain for OA care.Results: Fourteen studies assessed as being of high‐quality were included in the review, with the number of QIs ranging from 1 to 21. Four of the 14 studies solely assessed the quality of OA care, while the other studies assessed health care quality for a range of conditions that included OA. The quality of OA care as assessed by a meta‐analysis of QI pass rates across studies was suboptimal for all treatment domains (pass rates: pain and functional status assessment – 48.5%, 95% CI 32.6–64.6%; non‐drug treatment – 36.1%, 95% CI 27.8–44.7%; drug treatment – 37.5%, 95% CI 30.8–44.5%; surgical referral – 78.9%, 95% CI 57.4–94.2%).Conclusion: Despite efforts made at improving care for patients with OA, the wide divergence between evidence and consensus‐based recommended care and practice has been reaffirmed.
- 17 June 2015
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 21 (5) , 782-789
Assessing appropriateness of osteoarthritis care using quality indicators: a systematic review
Rationale, aims and objectives: Quality indicators (QIs) derived from the review of medical records, administrative databases, and patient questionnaires and interviews have been frequently used to assess the quality of osteoarthritis (OA) care. The purpose of this review is to summarize studies that have assessed the quality of OA care using QIs.Method: We systematically searched MEDLINE, EMBASE, CINAHL and PsycINFO for English‐language studies indexed by October 2014. Articles were included if they used any QIs for assessing the quality of OA care. We summarized the results of these studies, and with meta‐analysis, generated an overall conclusion about the quality of care as measured by QIs for each treatment domain for OA care.Results: Fourteen studies assessed as being of high‐quality were included in the review, with the number of QIs ranging from 1 to 21. Four of the 14 studies solely assessed the quality of OA care, while the other studies assessed health care quality for a range of conditions that included OA. The quality of OA care as assessed by a meta‐analysis of QI pass rates across studies was suboptimal for all treatment domains (pass rates: pain and functional status assessment – 48.5%, 95% CI 32.6–64.6%; non‐drug treatment – 36.1%, 95% CI 27.8–44.7%; drug treatment – 37.5%, 95% CI 30.8–44.5%; surgical referral – 78.9%, 95% CI 57.4–94.2%).Conclusion: Despite efforts made at improving care for patients with OA, the wide divergence between evidence and consensus‐based recommended care and practice has been reaffirmed.
- 1 November 2014
- Published by Elsevier in Complementary Therapies in Clinical Practice
- Vol. 20 (4) , 237-242
Australians with osteoarthritis; the use of and beliefs about complementary and alternative medicines
- 1 November 2014
- Published by Elsevier in Complementary Therapies in Clinical Practice
- Vol. 20 (4) , 237-242
Australians with osteoarthritis; the use of and beliefs about complementary and alternative medicines